112 related articles for article (PubMed ID: 8535026)
1. [Use of rhodamine 123 for the detection of multidrug resistance].
Canitrot Y; Lautier D
Bull Cancer; 1995 Sep; 82(9):687-97. PubMed ID: 8535026
[TBL] [Abstract][Full Text] [Related]
2. Relationships between rhodamine 123 transport, cell volume, and ion-channel function of P-glycoprotein.
Altenberg GA; Vanoye CG; Han ES; Deitmer JW; Reuss L
J Biol Chem; 1994 Mar; 269(10):7145-9. PubMed ID: 7510282
[TBL] [Abstract][Full Text] [Related]
3. Functional detection of MDR1/P170 and MRP/P190-mediated multidrug resistance in tumour cells by flow cytometry.
Feller N; Kuiper CM; Lankelma J; Ruhdal JK; Scheper RJ; Pinedo HM; Broxterman HJ
Br J Cancer; 1995 Sep; 72(3):543-9. PubMed ID: 7669559
[TBL] [Abstract][Full Text] [Related]
4. A comparison of rhodamine 123 accumulation and efflux in cells with P-glycoprotein-mediated and MRP-associated multidrug resistance phenotypes.
Twentyman PR; Rhodes T; Rayner S
Eur J Cancer; 1994; 30A(9):1360-9. PubMed ID: 7999426
[TBL] [Abstract][Full Text] [Related]
5. Expression and function of P-glycoprotein in human mesangial cells.
Bello-Reuss E; Ernest S
Am J Physiol; 1994 Nov; 267(5 Pt 1):C1351-8. PubMed ID: 7526696
[TBL] [Abstract][Full Text] [Related]
6. Unidirectional fluxes of rhodamine 123 in multidrug-resistant cells: evidence against direct drug extrusion from the plasma membrane.
Altenberg GA; Vanoye CG; Horton JK; Reuss L
Proc Natl Acad Sci U S A; 1994 May; 91(11):4654-7. PubMed ID: 7910961
[TBL] [Abstract][Full Text] [Related]
7. Involvement of glutathione in loss of technetium-99m-MIBI accumulation related to membrane MDR protein expression in tumor cells.
Moretti JL; Duran Cordobes M; Starzec A; de Beco V; Vergote J; Benazzouz F; Boissier B; Cohen H; Safi N; Piperno-Neumann S; Kouyoumdjian JC
J Nucl Med; 1998 Jul; 39(7):1214-8. PubMed ID: 9669397
[TBL] [Abstract][Full Text] [Related]
8. Protein kinase C isoenzymes, p53, accumulation of rhodamine 123, glutathione-S-transferase, topoisomerase II and MRP in multidrug resistant cell lines.
Utz I; Gekeler V; Ise W; Beck J; Spitaler M; Grunicke H; Hofmann J
Anticancer Res; 1996; 16(1):289-96. PubMed ID: 8615623
[TBL] [Abstract][Full Text] [Related]
9. Effects of vinblastine, colchicine, and verapamil on rhodamine 123 accumulation in human P-glycoprotein-positive leukemia cells.
Lautier D; Canitrot Y; Salmon JM
Anticancer Res; 1994; 14(6B):2589-95. PubMed ID: 7872686
[TBL] [Abstract][Full Text] [Related]
10. Modulation of rhodamine 123 uptake by nigericin in sensitive and multidrug resistant leukemic cells.
Canitrot Y; Lautier D; Viallet P; Salmon JM
Cancer Lett; 1994 Aug; 84(1):75-83. PubMed ID: 8076364
[TBL] [Abstract][Full Text] [Related]
11. Multidrug resistance-related proteins in primary choroidal melanomas and in vitro cell lines.
van der Pol JP; Blom DJ; Flens MJ; Luyten GP; de Waard-Siebinga I; Koornneef L; Scheper RJ; Jager MJ
Invest Ophthalmol Vis Sci; 1997 Nov; 38(12):2523-30. PubMed ID: 9375571
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of drug transport by genistein in multidrug-resistant cells expressing P-glycoprotein.
Castro AF; Altenberg GA
Biochem Pharmacol; 1997 Jan; 53(1):89-93. PubMed ID: 8960067
[TBL] [Abstract][Full Text] [Related]
13. Functional multidrug resistance phenotype associated with combined overexpression of Pgp/MDR1 and MRP together with 1-beta-D-arabinofuranosylcytosine sensitivity may predict clinical response in acute myeloid leukemia.
Schuurhuis GJ; Broxterman HJ; Ossenkoppele GJ; Baak JP; Eekman CA; Kuiper CM; Feller N; van Heijningen TH; Klumper E; Pieters R
Clin Cancer Res; 1995 Jan; 1(1):81-93. PubMed ID: 9815890
[TBL] [Abstract][Full Text] [Related]
14. 2'[(18)F]-fluoroethylrhodamine B is a promising radiotracer to measure P-glycoprotein function.
Trencsényi G; Kertész I; Krasznai ZT; Máté G; Szalóki G; Szabó Judit P; Kárpáti L; Krasznai Z; Márián T; Goda K
Eur J Pharm Sci; 2015 Jul; 74():27-35. PubMed ID: 25857708
[TBL] [Abstract][Full Text] [Related]
15. Reduced drug accumulation and multidrug resistance in human breast cancer cells without associated P-glycoprotein or MRP overexpression.
Lee JS; Scala S; Matsumoto Y; Dickstein B; Robey R; Zhan Z; Altenberg G; Bates SE
J Cell Biochem; 1997 Jun; 65(4):513-26. PubMed ID: 9178101
[TBL] [Abstract][Full Text] [Related]
16. In vitro and in vivo evaluation of WK-X-34, a novel inhibitor of P-glycoprotein and BCRP, using radio imaging techniques.
Jekerle V; Klinkhammer W; Scollard DA; Breitbach K; Reilly RM; Piquette-Miller M; Wiese M
Int J Cancer; 2006 Jul; 119(2):414-22. PubMed ID: 16646006
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of the ATP-binding cassette half-transporter, ABCG2 (Mxr/BCrp/ABCP1), in flavopiridol-resistant human breast cancer cells.
Robey RW; Medina-Pérez WY; Nishiyama K; Lahusen T; Miyake K; Litman T; Senderowicz AM; Ross DD; Bates SE
Clin Cancer Res; 2001 Jan; 7(1):145-52. PubMed ID: 11205902
[TBL] [Abstract][Full Text] [Related]
18. Kinetic analysis of calcein and calcein-acetoxymethylester efflux mediated by the multidrug resistance protein and P-glycoprotein.
Essodaigui M; Broxterman HJ; Garnier-Suillerot A
Biochemistry; 1998 Feb; 37(8):2243-50. PubMed ID: 9485370
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of multidrug resistant phenotype by flow cytometry with monoclonal antibodies and functional tests.
Lizard G; Maynadié M; Roignot P; Lizard-Nacol S; Poupon MF
Bull Cancer; 1995 Mar; 82(3):211-7. PubMed ID: 7655150
[TBL] [Abstract][Full Text] [Related]
20. Transport proteins in drug resistance: detection and prognostic significance in acute myeloid leukemia.
Broxterman HJ; Schuurhuis GJ
J Intern Med Suppl; 1997; 740():147-51. PubMed ID: 9350197
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
